Surgery Partners Inc (SGRY)
25.28
-0.10
(-0.41%)
USD |
NASDAQ |
Apr 24, 15:38
Surgery Partners Cash from Investing (TTM): -225.60M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -225.60M |
September 30, 2023 | -239.70M |
June 30, 2023 | -268.40M |
March 31, 2023 | -331.50M |
December 31, 2022 | -307.90M |
September 30, 2022 | -425.70M |
June 30, 2022 | -472.40M |
March 31, 2022 | -364.50M |
December 31, 2021 | -331.70M |
September 30, 2021 | -236.90M |
June 30, 2021 | -106.60M |
March 31, 2021 | -95.00M |
December 31, 2020 | -88.40M |
September 30, 2020 | -16.60M |
June 30, 2020 | -64.80M |
March 31, 2020 | -74.50M |
December 31, 2019 | -85.20M |
Date | Value |
---|---|
September 30, 2019 | -124.10M |
June 30, 2019 | -117.00M |
March 31, 2019 | -110.90M |
December 31, 2018 | -128.90M |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | -80.58M |
March 31, 2017 | -172.52M |
December 31, 2016 | -184.75M |
September 30, 2016 | -249.75M |
June 30, 2016 | -255.47M |
March 31, 2016 | -148.50M |
December 31, 2015 | -134.84M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-472.40M
Minimum
Jun 2022
-16.60M
Maximum
Sep 2020
-209.29M
Average
-225.60M
Median
Dec 2023
Cash from Investing (TTM) Benchmarks
DaVita Inc | -771.80M |
Healthcare Services Group Inc | -3.293M |
Encompass Health Corp | -602.80M |
The Oncology Institute Inc | 62.64M |
American Oncology Network Inc | -- |